Abstract
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Acute Disease
-
Anemia, Aplastic / mortality
-
Anemia, Aplastic / therapy*
-
Bone Marrow Transplantation*
-
Graft vs Host Disease / etiology*
-
HLA Antigens / genetics
-
Histocompatibility Testing
-
Humans
-
Immunologic Deficiency Syndromes / etiology
-
Immunosuppression Therapy
-
Leukemia / mortality
-
Leukemia / therapy*
-
Leukemia, Lymphoid / mortality
-
Leukemia, Lymphoid / therapy
-
Leukemia, Myeloid / mortality
-
Leukemia, Myeloid / therapy
-
Transplantation Immunology*
-
Transplantation, Homologous* / adverse effects